Viatris VTRS
NASDAQ VTRS
$16.08 -0.16 (-0.98%)
At close: Aug 20, 2026 · 12:59 PM UTC

Viatris (VTRS) Net Income Growth (5y) (2024 - 2026)

Viatris (VTRS) Net Income Growth (5y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.96 Bn 43.00 Bn -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 15.71%
Mar 31, 2026 16.76%
Dec 31, 2025 17.97%
Sep 30, 2025 5.38%
Jun 30, 2025 -38.58%
Mar 31, 2025 -171.77%
Dec 31, 2024 -100.92%